Nicolet Advisory Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,309
Closed -$203K 421
2025
Q1
$203K Sell
3,309
-296
-8% -$24.4K 0.02% 366
2024
Q4
$311K Buy
3,605
+254
+8% +$27.5K 0.03% 285
2024
Q3
$386K Buy
3,351
+323
+11% +$43.1K 0.04% 245
2024
Q2
$432K Buy
3,028
+251
+9% +$33.3K 0.04% 221
2024
Q1
$347K Buy
2,777
+138
+5% +$16.4K 0.04% 243
2023
Q4
$280K Sell
2,639
-524
-17% -$51.8K 0.03% 255
2023
Q3
$282K Buy
3,163
+145
+5% +$12.8K 0.03% 237
2023
Q2
$239K Buy
+3,018
New +$247K 0.03% 273

Other funds holding NVO

Nicolet Advisory Services's NVO Position: Q2 2025 in Review

Nicolet Advisory Services sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 3,309 shares — an estimated $203K sold.

Nicolet Advisory Services first reported a position in NVO in Q2 2023 and held it in 8 quarters. The position peaked at $432K in Q2 2024. 1,481 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Nicolet Advisory Services reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Nicolet Advisory Services sold 3,309 Novo Nordisk shares in Q2 2025, an estimated $203K.
  • Nicolet Advisory Services first reported a position in Novo Nordisk in Q2 2023 and held it in 8 quarters.
  • Nicolet Advisory Services's Novo Nordisk position peaked at $432K in Q2 2024.
  • 1,481 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Nicolet Advisory Services's 13F filing for Q2 2025, filed 13 Aug 2025.